Cell Medica Ltd and Baylor College of Medicine in the US have agreed to collaborate on a cell-based treatment for cancers associated with the Epstein Barr virus that involves an ex vivo procedure enabling a patient’s own cells to tackle the disease.
Cell Medica Ltd and Baylor College of Medicine in the US have agreed to collaborate on a cell-based treatment for cancers associated with the Epstein Barr virus that involves an ex vivo procedure enabling a patient’s own cells to tackle the disease.